Form 8-K HEALTHEQUITY, INC. For: Mar 19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
HealthEquity, Inc (HQY) PT Raised to $97 at BofA Securities
March 20, 2024 4:41 AM EDTBofA Securities analyst Allen Lutz raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $97.00 (from $93.00) while maintaining a Buy rating.
The analyst comments "HealthEquity reported a strong quarter, with strong expense management in Technology & Development the largest upside driver versus our model. FY25 revenue and EBITDA guidance was in line... More
HealthEquity, Inc (HQY) PT Raised to $110 at BTIG
March 20, 2024 4:11 AM EDTBTIG analyst David Larsen raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $110.00 (from $100.00) while maintaining a Buy rating.
The analyst comments "On Tuesday, 3/19/24 AMC, HQY reported excellent F4Q:24 results. Total revenue of $262.4M +12% y/y exceeded BTIG / consensus estimates of $260.7M / $258.7M and adjusted EBITDA of $98.8M +34% y/y also exceeded BTIG / consensus estimates of $98M / $91.5M. HQY re-affirmed revenue guidance for... More
